Crescentis Capital board to review rights issue progress on Sep 29

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Crescentis Capital Limited board meeting scheduled for September 29, 2026
  • Agenda includes reviewing progress on proposed rights issue fund raising
  • Fund Raising Committee constituted on May 29, 2026 to oversee the process
  • Proposal involves raising funds via equity shares on a rights basis
  • Subject to regulatory and statutory approvals as deemed appropriate
powered bylight_fuzz_icon
51796788

*this image is generated using AI for illustrative purposes only.

Crescentis Capital Limited will convene a Board of Directors meeting on Tuesday, September 29, 2026. The primary agenda is to review updates and progress regarding a proposed fund raising exercise via equity shares on a rights basis.

The Board will assess the work undertaken by the Fund Raising Committee, which was constituted during the Board Meeting held on May 29, 2026. This committee was tasked with evaluating the proposal for raising funds through rights issues, subject to necessary regulatory and statutory approvals.

Meeting Agenda and Scope

The intimation filed with BSE Limited under Regulation 29 of the SEBI Listing Regulations outlines the specific focus of the upcoming session. The Board intends to examine the status of the rights issue proposal as permitted under applicable law.

Key aspects of the meeting include:

  • Reviewing progress made by the Fund Raising Committee since its formation in May 2026.
  • Considering the proposal for raising funds by way of equity shares on a rights basis.
  • Evaluating regulatory and statutory approvals required for the transaction.
  • Addressing any other business brought before the Board with the Chair's permission.

Regulatory Context

This disclosure serves as prior intimation pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company, formerly known as Som Datt Finance Corporation Limited, continues to operate under its current corporate structure while pursuing capital market strategies.

The meeting date has been fixed for late September 2026, providing a clear timeline for stakeholders to anticipate further disclosures regarding the capital structure changes.

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-1.85%-3.21%-18.13%-26.29%+156.41%

What specific capital allocation strategy will Crescentis Capital pursue once the rights issue proceeds are secured?

How might the dilution from the rights issue impact existing shareholders' voting power and earnings per share?

What is the anticipated timeline for receiving final SEBI and statutory approvals following the board's review?

Crescentis Capital shareholders approve all five AGM resolutions

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • All five resolutions at Crescentis Capital's 33rd AGM passed with majority support
  • Promoters abstained from voting on CEO reappointments due to conflict of interest
  • Public shareholders voted 99.876% in favour of Bhavanam Ruthvik Reddy's terms
  • Promoter group voted unanimously for financial adoption and MD reappointment
  • ESOP grant authority for >1% issued capital was approved by members
powered bylight_fuzz_icon
49296134

*this image is generated using AI for illustrative purposes only.

Crescentis Capital Limited shareholders approved all five resolutions proposed at its 33rd Annual General Meeting on August 26, 2026. The vote covered the adoption of FY26 financials, key board reappointments, and employee stock option grants.

The meeting was conducted via video conferencing in compliance with Ministry of Corporate Affairs circulars. Dr. Bhaskara Rao Bollineni, Chairman, confirmed the requisite quorum. Mr. Arun Kumar Gupta served as the Scrutinizer for the remote e-voting process conducted through National Securities Depository Limited (NSDL).

Voting Results

All resolutions passed with overwhelming support. The promoter group held 12,756,347 shares as on the cut-off date of August 21, 2026. Public non-institutional shareholders held 190,538 shares.

Resolution Votes In Favour Votes Against % In Favour Status
Adoption of FY26 Financials 12,946,649 236 99.998% Passed
Reappointment of Ruthvik Reddy (Rotation) 190,302 236 99.876% Passed
Reappointment of Subba Rao Meka (MD) 12,945,439 236 99.998% Passed
Reappointment of Ruthvik Reddy (CEO, 5 Years) 190,302 236 99.876% Passed
ESOP Grant Approval 12,945,439 236 99.998% Passed

Director Reappointments

Members reappointed Mr. Bhavanam Ruthvik Reddy as Whole-Time Director & CEO by rotation and for a further five-year term. Mr. Subba Rao Veeravenkata Meka was reappointed as Managing Director for five years.

The promoters abstained from voting on the resolutions concerning Mr. Reddy’s reappointments, as they were interested parties. Consequently, these resolutions were decided solely by public non-institutional shareholders, who voted in favour by 99.876%. The promoter group voted unanimously in favour of the other three resolutions.

Other Business

The AGM also approved the grant of Employee Stock Options to an identified employee equal to or exceeding one percent of issued capital. The audited financial statements for FY26 were adopted with 99.998% support.

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-1.85%-3.21%-18.13%-26.29%+156.41%

How might the approved Employee Stock Option (ESOP) grants impact future share dilution and earnings per share for Crescentis Capital?

What strategic initiatives is CEO Ruthvik Reddy expected to prioritize during his newly secured five-year tenure?

Given the overwhelming approval of FY26 financials, what key performance indicators drove the company's results and how do they compare to industry peers?

More News on Crescentis Capital

1 Year Returns:-26.29%